• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

H Lundbeck A/S

+ Add to Watchlist


116.7000 DKK 2.9000 2.42%

As of 11:02:36 ET on 10/20/2014.

Snapshot for H Lundbeck A/S (LUN)

Open: 119.6000 Day's Range: 114.5000 - 120.2000 Volume: 156,660
Previous Close: 119.6000 52wk Range: 111.5000 - 173.6000 1-Yr Rtn: +1.04%

Stock Chart for LUN

No chart data available.
  • LUN:DC 116.7000
  • 1D
  • 1M
  • 1Y
Interactive LUN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LUN

Current P/E Ratio (ttm) 29.9378
Estimated P/E(12/2014) 33.5441
Relative P/E vs. KFX 1.4241
Earnings Per Share (DKK) (ttm) 3.8981
Est. EPS (DKK) (12/2014) 3.4790
Est. PEG Ratio -
Market Cap (M DKK) 22,917.72
Shares Outstanding (M) 196.38
30 Day Average Volume 187,954
Price/Book (mrq) 1.7097
Price/Sale (ttm) 1.6144
Dividend Indicated Gross Yield 2.37%
Cash Dividend (DKK) 2.7700
Dividend Ex-Date 03/27/2014
5 Year Dividend Growth 3.79%
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LUN

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for LUN

H. Lundbeck A/S is an international pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of psychiatric and neurological disorders. The Company focuses on mood disorders, dementia, anxiety, and sleep disorders. Lundbeck does research both in-house and in cooperation with research centers. The Company markets its products worldwide.

Thorleif KrarupDeputy ChairmanUlf WiinbergPresident/CEO
Anders GotzscheExec VP/CFOAnders Gersel PedersenExec VP:Research & Dev
More Company Profile & Key Executives for LUN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil